Faezeh Shekari

Faezeh Shekari is the CEO of Celer Diagnostics, a biotech firm specializing in liquid biopsy solutions using extracellular vesicles (EVs). With an academic background and experience as an Assistant Professor at Royan Institute, Faezeh has expertise in stem cell biology, molecular and cellular biology, and GMP-grade EV production. As the Chair of the International Society for Extracellular Vesicles (ISEV) Rigor and Standardization task force, Faezeh leads efforts to establish industry best practices and guidelines for EV production. With a strong foundation in university teaching spanning cell biology, molecular biology, bioinformatics, and bioethics, she brings a comprehensive understanding of biomedical research and its ethical implications. Faezeh's work covers various facets of EV research, from fundamental biology to translational applications, with a primary focus on using EVs for therapy and diagnosis. Dedicated to advancing EV biology, she is committed to translating this knowledge into clinical solutions that improve patient outcomes.

· Total Publications: More than 50

· Publications in the last three years: 27 articles

· Total Citations (Google Scholar): 9760

· h-index (Google Scholar):14

· i10-index (Google Scholar): 24

• Principal investigator of clinical trial phase I on Therapeutic Evaluation of MSC-EVs in POF patients
• International Biobanking Protocol Collection and Position Statement
• Comparative Analysis of EVs as Drug Delivery Vehicles

• 3rd International Symposium on Stem Cells and Regenerative Medicine: With a Focus on Extracellular Vesicles (MashhadStemCells-2022)
• 4th International Cancer Symposium; From Bench to Bedside (Royan, 2023)

• Chairperson and invited speaker at 19th Royan International Congress on Stem Cell Biology & Technology (September 2023): Large-Scale Production of Therapeutic EVs from Cell Culture- Derived Conditioned Medium
• COMSTECH virtual innovation lab (July 2022) EVs: different sources, different applications
• PCMD-Royan hybrid webinars (May 2022): MSC-EV: considerations and therapeutic applications
• ISEV-EVclub (March 2022): CCM-EVs: considerations and clinical aspects
• ISEV education day (May 2021): Conditioned medium-derived EVs
• American Society for Biochemistry and Molecular Biology symposium (July 2021): considerations of the culture medium task force (Plenary session 4)
• ISEV Infectious disease (Jan 2021, USA): EVs subpopulation and COVID-19

• 2023-Now: American Society of Clinical Oncology (ASCO)
• 2017-Now: International Society for Extracellular Vesicles (ISEV)
• 2015- Now: vice chairman of the Iranian Proteomics Society
• 2007 -Now: Iranian Proteomics Society
• 2009-2010: International Society for Stem Cell Research (ISSCR)

• Journal of Extracellular Vesicles (Impact Factor: 17.337)
• Guest editor for a special issue in Frontiers in Cell and Developmental Biology (Impact Factor: 6.684)
• Cell Journal (Impact Factor: 3)

Bioinformatics for biology students, Cell Biology, Molecular Assessments of the Cell, Cancer, Proteomics, High-throughput Data Analysis, Advanced cell biology, Regenerative medicine, Bio-ethics, Programming with R language for biology students